logo
logo

OSE Immunotherapeutics Receives €5.2 M in Public Funding for the Clinical Development of CoVepiT, Its Second Generation COVID-19 Vaccine

OSE Immunotherapeutics Receives €5.2 M in Public Funding for the Clinical Development of CoVepiT, Its Second Generation COVID-19 Vaccine

12/18/20, 6:39 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/FR.svgnantes
Money raised
€5.2 million
Regulatory News:

Company Info

Company
Bpifrance
Location
nantes, pays de la loire, france
Additional Info
For more information, please visit: www.bpifrance.fr and presse.bpifrance.fr - Follow us on Twitter: @Bpifrance - @BpifrancePresse

Related People